Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 May 16:14:1158573.
doi: 10.3389/fendo.2023.1158573. eCollection 2023.

Distinct serum steroid profiles between adrenal Cushing syndrome and Cushing disease

Chang Gao  1 , Li Ding  1 , Xiaona Zhang  1 , Menghua Yuan  1 , Shaofang Tang  1 , Wei Li  2 , Yuanyuan Ye  1 , Ming Liu  1 , Qing He  1
Affiliations

Distinct serum steroid profiles between adrenal Cushing syndrome and Cushing disease

Chang Gao et al. Front Endocrinol (Lausanne). .

Abstract

Background: Differentiating between adrenal Cushing syndrome (adrenal CS) and Cushing disease (CD) can be challenging if there are equivocal or falsely elevated adrenocorticotropic hormone (ACTH) values. We aim to investigate the diagnostic value of serum steroid profiles in differentiating adrenal CS from CD.

Method: A total of 11 serum steroids in adrenal CS (n = 13) and CD (n = 15) were analyzed by liquid chromatography with tandem mass spectrometry (LC-MS/MS). Age- and gender-specific steroid ratios were generated by dividing the actual steroid concentration by the upper limit of the relevant reference range. A principal component analysis (PCA) and an orthogonal partial least squares discriminant analysis (OPLS-DA) were performed.

Results: The PCA and OPLS-DA analyses showed distinct serum steroid profiles between adrenal CS and CD. Dehydroepiandrosterone sulfate (DHEA-S), dehydroepiandrosterone (DHEA), and androstenedione ratios were identified as biomarkers for discrimination by variable importance in projection (VIP) in combination with t-tests. The sensitivity and specificity of DHEA-S ratios <0.40 were 92.31% (95% CI 64.0%-99.8%) and 93.33% (95% CI 68.1%-99.8%), respectively, in identifying adrenal CS. The sensitivity and specificity of DHEA ratios <0.18 were 100% (95% CI 75.3%-100.0%) and 100% (95% CI 78.2%-100.0%), respectively, in identifying adrenal CS.

Conclusion: Our data support the clinical use of the DHEA-S and DHEA ratios in the differential diagnosis of adrenal CS and CD, especially when falsely elevated ACTH is suspected.

Keywords: Cushing syndrome; dehydroepiandrosterone sulfate (DHEA-S); mass spectrometry; orthogonal partial least squares discriminant analysis (OPLS-DA); serum steroids.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Flow chart of identification of study population.
Figure 2
Figure 2
Principal component analysis (PCA) score plot of adrenal Cushing syndrome (adrenal CS) group and Cushing disease (CD) group. The x- and y-axes represent the first principal component and the second principal component after PCA, respectively. The model parameters were R 2 X = 0.79 and Q 2 = 0.36. PCA, principal component analysis.
Figure 3
Figure 3
The orthogonal partial least squares discriminant analysis (OPLS-DA) model for the classification of adrenal Cushing syndrome (adrenal CS) and Cushing disease (CD). (A) Score plot of first predictive component (t[1]) vs. first orthogonal component (to[1]) of established OPLS-DA model based on the adrenal CS vs. CD dataset. The model parameters were as follows: R 2 X = 0.788, R 2 Y = 0.899, and Q 2 Y = 0.807. (B) Permutation test of 200 permutations of the OPLS-DA model. OPLS-DA, orthogonal partial least squares discriminant analysis.
Figure 4
Figure 4
Loading plot and S-plot for identifying putative steroid biomarkers between adrenal Cushing syndrome (adrenal CS) and Cushing disease (CD). (A) P1 loading plot of the OPLS-DA model. p[1] provided confidence intervals of each loading value. (B) S-plot of OPLS-DA for adrenal CS and CD. The p[1]-axis describes the magnitude of each variable. The p(corr)[1]-axis represents the reliability of each variable. Ideal steroid biomarkers have high magnitude and high reliability. T, testosterone; DHEA, dehydroepiandrosterone; P, progesterone; 17-OHP, 17-OH-progesterone; A4, androstenedione; DOC, 11-deoxycorticosterone; 11-DOC, 11-deoxycortisol; DHEA-S, dehydroepiandrosterone-sulfate.
See this image and copyright information in PMC

References

    1. Klose M, Kofoed-Enevoldsen A, Ostergaard Kristensen L. Single determination of plasma ACTH using an immunoradiometric assay with high detectability differentiates between ACTH-dependent and -independent cushing's syndrome. Scandinavian J Clin Lab Invest (2002) 62(1):33–7. doi: 10.1080/003655102753517181 - DOI - PubMed
    1. Arnaldi G, Angeli A, Atkinson AB, Bertagna X, Cavagnini F, Chrousos GP, et al. Diagnosis and complications of cushing's syndrome: a consensus statement. J Clin Endocrinol Metab (2003) 88(12):5593–602. doi: 10.1210/jc.2003-030871 - DOI - PubMed
    1. Pecori Giraldi F, Saccani A, Cavagnini F. Assessment of ACTH assay variability: a multicenter study. Eur J endocrinology (2011) 164(4):505–12. doi: 10.1530/EJE-10-0962 - DOI - PubMed
    1. Hong AR, Kim JH, Hong ES, Kim IK, Park KS, Ahn CH, et al. Limited diagnostic utility of plasma adrenocorticotropic hormone for differentiation between adrenal cushing syndrome and cushing disease. Endocrinol Metab (Seoul Korea) (2015) 30(3):297–304. doi: 10.3803/EnM.2015.30.3.297 - DOI - PMC - PubMed
    1. Greene LW, Geer EB, Page-Wilson G, Findling JW, Raff H. Assay-specific spurious ACTH results lead to misdiagnosis, unnecessary testing, and surgical misadventure-a case series. J Endocrine Society (2019) 3(4):763–72. doi: 10.1210/js.2019-00027 - DOI - PMC - PubMed